Ophthalmology

Findings support lower doses of atropine in pediatric myopia Rx

(HealthDay)—Adverse effects are less frequent at lower doses of atropine, and higher doses are not more effective in reducing progression of myopia in children, according to a meta-analysis published online May 11 in JAMA ...

Ophthalmology

ARVO: Latanoprost halts myopia progression in animal study

(HealthDay)—Daily topical latanoprost may help stop progression of myopia, offering a potential new treatment for the condition, according to an experimental study presented at the annual meeting of the Association for ...

Ophthalmology

Myopia cell discovered in retina

Northwestern Medicine scientists have discovered a cell in the retina that may cause myopia when it dysfunctions. The dysfunction may be linked to the amount of time a child spends indoors and away from natural light.

Ophthalmology

New genetic risk factors for myopia discovered

Myopia, also known as short-sightedness or near-sightedness, is the most common disorder affecting the eyesight and it is on the increase. The causes are both genetic and environmental. The Consortium for Refractive Error ...

Ophthalmology

Half the world to be short-sighted by 2050

Half the world's population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends continue, says a study published ...

page 6 from 11